Hyaluronan regulation of endothelial barrier function in cancer

Advances in Cancer Research

Volumn 123, Issue , 2014, Pages 191-209

  Singleton, Patrick A ^a,b  

^a Section of Pulmonary and Critical Care   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cancer metastasis; Caveolin enriched microdomain; CD44; HABP2; Hyaluronidase; RHAMM; TLR4; Tumor angiogenesis; Tumor cell extravasation; Vascular integrity

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; HYALURONIDASE; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; CAVEOLIN; GLYCOSAMINOGLYCAN; HERMES ANTIGEN;

ANGIOGENESIS; ARTICLE; CELL JUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; LIPID RAFT; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; ANIMAL; CELL MEMBRANE; CHEMISTRY; DISEASE COURSE; ENDOTHELIUM; GENE EXPRESSION REGULATION; METABOLISM; MOLECULAR WEIGHT; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CAVEOLINS; DISEASE PROGRESSION; ENDOTHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; MEMBRANE MICRODOMAINS; MOLECULAR WEIGHT; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN STRUCTURE, TERTIARY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84904890529     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800092-2.00007-1     Document Type: Chapter

References (119)

1. Abecassis I., Olofsson B., Schmid M., Zalcman G., Karniguian A. RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Experimental Cell Research 2003, 291:363-376.
2. Almond A. Hyaluronan. Cellular and Molecular Life Sciences 2007, 64:1591-1596.
3. Arai E., Nishida Y., Wasa J., Urakawa H., Zhuo L., Kimata K., et al. Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo. British Journal of Cancer 2011, 105:1839-1849.
4. Arnold F., West D.C. Angiogenesis in wound healing. Pharmacology & Therapeutics 1991, 52:407-422.
5. Auvinen P., Tammi R., Kosma V.M., Sironen R., Soini Y., Mannermaa A., et al. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. International Journal of Cancer 2013, 132:531-539.
6. Aytes A., Mitrofanova A., Kinkade C.W., Lefebvre C., Lei M., Phelan V., et al. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:E3506-E3515.
7. Benitez A., Yates T.J., Lopez L.E., Cerwinka W.H., Bakkar A., Lokeshwar V.B. Targeting hyaluronidase for cancer therapy: Antitumor activity of sulfated hyaluronic acid in prostate cancer cells. Cancer Research 2011, 71:4085-4095.
8. Bernert B., Porsch H., Heldin P. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1). The Journal of Biological Chemistry 2011, 286:42349-42359.
9. Bollyky P.L., Falk B.A., Wu R.P., Buckner J.H., Wight T.N., Nepom G.T. Intact extracellular matrix and the maintenance of immune tolerance: High molecular weight hyaluronan promotes persistence of induced CD4+CD25+regulatory T cells. Journal of Leukocyte Biology 2009, 86:567-572.
10. Bourguignon L.Y., Singleton P.A., Diedrich F., Stern R., Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. The Journal of Biological Chemistry 2004, 279:26991-27007.
11. Cantor J.O. Potential therapeutic applications of hyaluronan in the lung. International Journal of Chronic Obstructive Pulmonary Disease 2007, 2:283-288.
12. Cantor J.O., Nadkarni P.P. Hyaluronan: The Jekyll and Hyde molecule. Inflammation & Allergy Drug Targets 2006, 5:257-260.
13. Chatterjee M., Sequeira L., Jenkins-Kabaila M., Dubyk C.W., Pathak S., van Golen K.L. Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions. Journal of Signal Transduction 2011, 2011:541851.
14. Chen J. Is Src the key to understanding metastasis and developing new treatments for colon cancer?. Nature Clinical Practice. Gastroenterology & Hepatology 2008, 5:306-307.
15. Chetty C., Vanamala S.K., Gondi C.S., Dinh D.H., Gujrati M., Rao J.S. MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cellular Signalling 2012, 24:549-559.
16. Chiang A.C., Massague J. Molecular basis of metastasis. The New England Journal of Medicine 2008, 359:2814-2823.
17. Cho S.H., Park Y.S., Kim H.J., Kim C.H., Lim S.W., Huh J.W., et al. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. International Journal of Oncology 2012, 41:211-218.
18. Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biology 2001, 20:499-508.
19. Curry F.R. Microvascular solute and water transport. Microcirculation 2005, 12:17-31.
20. Dang S., Peng Y., Ye L., Wang Y., Qian Z., Chen Y., et al. Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7. Clinical & Developmental Immunology 2013, 2013:712561.
21. Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Developmental Cell 2009, 16:209-221.
22. Dickinson L.E., Gerecht S. Micropatterned surfaces to study hyaluronic acid interactions with cancer cells. Journal of Visualized Experiments 2010, 46:2413.
23. Draffin J.E., McFarlane S., Hill A., Johnston P.G., Waugh D.J. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Research 2004, 64:5702-5711.
24. Droller M.J. Expression of cathepsin D in urothelial carcinoma of the urinary bladder: An immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices. The Journal of Urology 2003, 170:671-672.
25. Flamme I., Frolich T., Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. Journal of Cellular Physiology 1997, 173:206-210.
26. Flynn K.M., Michaud M., Canosa S., Madri J.A. CD44 regulates vascular endothelial barrier integrity via a PECAM-1 dependent mechanism. Angiogenesis 2013, 16:689-705.
27. Folkman J. Tumor angiogensis: Role in regulation of tumor growth. The Symposium/The Society for Developmental Biology 1974, 30:43-52.
28. Folkman J., Szabo S., Stovroff M., McNeil P., Li W., Shing Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Annals of Surgery 1991, 214:414-425. discussion 426-417.
29. Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: Its nature, distribution, functions and turnover. Journal of Internal Medicine 1997, 242:27-33.
30. Fujisaki T., Tanaka Y., Fujii K., Mine S., Saito K., Yamada S., et al. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Research 1999, 59:4427-4434.
31. Furlan S., La Penna G., Perico A., Cesaro A. Hyaluronan chain conformation and dynamics. Carbohydrate Research 2005, 340:959-970.
32. Futamura N., Urakawa H., Arai E., Kozawa E., Ishiguro N., Nishida Y. Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer. Clinical & Experimental Metastasis 2013, 30:595-606.
33. Gaffney J., Matou-Nasri S., Grau-Olivares M., Slevin M. Therapeutic applications of hyaluronan. Molecular BioSystems 2010, 6:437-443.
34. Gao F., Yang C.X., Mo W., Liu Y.W., He Y.Q. Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clinical and Investigative Medicine 2008, 31:E106-E116.
35. Girish K.S., Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sciences 2007, 80:1921-1943.
36. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
37. Henry C.B., Duling B.R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. The American Journal of Physiology 1999, 277:H508-H514.
38. Hirose Y., Saijou E., Sugano Y., Takeshita F., Nishimura S., Nonaka H., et al. Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:4263-4268.
39. Itano N., Kimata K. Mammalian hyaluronan synthases. IUBMB Life 2002, 54:195-199.
40. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annual Review of Cell and Developmental Biology 2007, 23:435-461.
41. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiological Reviews 2011, 91:221-264.
42. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nature Reviews. Cancer 2009, 9:239-252.
43. Karbownik M.S., Nowak J.Z. Hyaluronan: Towards novel anti-cancer therapeutics. Pharmacological Reports 2013, 65:1056-1074.
44. Khuon S., Liang L., Dettman R.W., Sporn P.H., Wysolmerski R.B., Chew T.L. Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: A three-dimensional FRET study. Journal of Cell Science 2010, 123:431-440.
45. Kim Y., Lee Y.S., Choe J., Lee H., Kim Y.M., Jeoung D. CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. The Journal of Biological Chemistry 2008, 283:22513-22528.
46. Kobayashi H., Boelte K.C., Lin P.C. Endothelial cell adhesion molecules and cancer progression. Current Medicinal Chemistry 2007, 14:377-386.
47. Kosunen A., Pirinen R., Ropponen K., Pukkila M., Kellokoski J., Virtaniemi J., et al. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncology 2007, 43:51-59.
48. Kozar R.A., Peng Z., Zhang R., Holcomb J.B., Pati S., Park P., et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesthesia and Analgesia 2011, 112:1289-1295.
49. Krupinski J., Ethirajan P., Font M.A., Turu M.M., Gaffney J., Kumar P., et al. Changes in hyaluronan metabolism and RHAMM receptor expression accompany formation of complicated carotid lesions and may be pro-angiogenic mediators of intimal neovessel growth. Biomarker Insights 2008, 2:361-367.
50. Lataillade J.J., Albanese P., Uzan G. Implication of hyaluronic acid in normal and pathological angiogenesis. Application for cellular engineering. Annales de Dermatologie et de Vénéréologie 2010, 137(Suppl. 1):S15-S22.
51. Lennon F.E., Singleton P.A. Hyaluronan regulation of vascular integrity. American Journal of Cardiovascular Disease 2011, 1:200-213.
52. Lennon F.E., Singleton P.A. The Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology. American Journal of Physiology. Lung Cellular and Molecular Physiology 2011, 301:L137-L147.
53. Leong T.T., Fearon U., Veale D.J. Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis. Current Rheumatology Reports 2005, 7:325-329.
54. Liao Y.H., Jones S.A., Forbes B., Martin G.P., Brown M.B. Hyaluronan: Pharmaceutical characterization and drug delivery. Drug Delivery 2005, 12:327-342.
55. Liu Y.Y., Lee C.H., Dedaj R., Zhao H., Mrabat H., Sheidlin A., et al. High-molecular-weight hyaluronan-A possible new treatment for sepsis-induced lung injury: A preclinical study in mechanically ventilated rats. Critical Care 2008, 12:R102.
56. Mambetsariev N., Mirzapoiazova T., Mambetsariev B., Sammani S., Lennon F.E., Garcia J.G., et al. Hyaluronic acid binding protein 2 is a novel regulator of vascular integrity. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:483-490.
57. Marrero-Diaz R., Bravo-Cordero J.J., Megias D., Garcia M.A., Bartolome R.A., Teixido J., et al. Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion. Cell Motility and the Cytoskeleton 2009, 66:48-61.
58. Matou-Nasri S., Gaffney J., Kumar S., Slevin M. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin. International Journal of Oncology 2009, 35:761-773.
59. Mierke C.T. Cancer cells regulate biomechanical properties of human microvascular endothelial cells. The Journal of Biological Chemistry 2011, 286:40025-40037.
60. Miki Y., Teramura T., Tomiyama T., Onodera Y., Matsuoka T., Fukuda K., et al. Hyaluronan reversed proteoglycan synthesis inhibited by mechanical stress: Possible involvement of antioxidant effect. Inflammation Research 2010, 59:471-477.
61. Mine S., Fujisaki T., Kawahara C., Tabata T., Iida T., Yasuda M., et al. Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44. Experimental Cell Research 2003, 288:189-197.
62. Misra S., Heldin P., Hascall V.C., Karamanos N.K., Skandalis S.S., Markwald R.R., et al. Hyaluronan-CD44 interactions as potential targets for cancer therapy. The FEBS Journal 2011, 278:1429-1443.
63. Mitchell M.J., King M.R. Physical Biology in Cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells. American Journal of Physiology. Cell Physiology 2014, 306:C89-C97.
64. Murray D., Morrin M., McDonnell S. Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism. Anticancer Research 2004, 24:489-494.
65. Nalla A.K., Gorantla B., Gondi C.S., Lakka S.S., Rao J.S. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Therapy 2010, 17:599-613.
66. Nandi A., Estess P., Siegelman M.H. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. The Journal of Biological Chemistry 2000, 275:14939-14948.
67. Olczyk P., Komosinska-Vassev K., Winsz-Szczotka K., Kuznik-Trocha K., Olczyk K. Hyaluronan: Structure, metabolism, functions, and role in wound healing. Postȩpy Higieny i Medycyny Doświadczalnej (Online) 2008, 62:651-659.
68. Olofsson B., Porsch H., Heldin P. Knock-down of CD44 regulates endothelial cell differentiation via NFkappaB-mediated chemokine production. PLoS One 2014, 9:e90921.
69. Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours. European Journal of Cancer 2010, 46:1271-1277.
70. Otrock Z.K., Mahfouz R.A., Makarem J.A., Shamseddine A.I. Understanding the biology of angiogenesis: Review of the most important molecular mechanisms. Blood Cells, Molecules & Diseases 2007, 39:212-220.
71. Pardue E.L., Ibrahim S., Ramamurthi A. Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis 2008, 4:203-214.
72. Park D., Kim Y., Kim H., Kim K., Lee Y.S., Choe J., et al. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFbeta receptor interaction via CD44-PKCdelta. Molecules and Cells 2012, 33:563-574.
73. Peinado H., Lavotshkin S., Lyden D. The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts. Seminars in Cancer Biology 2011, 21:139-146.
74. Potente M., Gerhardt H., Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146:873-887.
75. Rahn J.J., Chow J.W., Horne G.J., Mah B.K., Emerman J.T., Hoffman P., et al. MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1. Clinical & Experimental Metastasis 2005, 22:475-483.
76. Reitsma S., Slaaf D.W., Vink H., van Zandvoort M.A., oude Egbrink M.G. The endothelial glycocalyx: Composition, functions, and visualization. Pflugers Archiv: European Journal of Physiology 2007, 454:345-359.
77. Reymond N., d'Agua B.B., Ridley A.J. Crossing the endothelial barrier during metastasis. Nature Reviews. Cancer 2013, 13:858-870.
78. Reymond N., Riou P., Ridley A.J. Rho GTPases and cancer cell transendothelial migration. Methods in Molecular Biology 2012, 827:123-142.
79. Ricciardelli C., Ween M.P., Lokman N.A., Tan I.A., Pyragius C.E., Oehler M.K. Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer. BMC Cancer 2013, 13:476.
80. Rubio-Gayosso I., Platts S.H., Duling B.R. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. American Journal of Physiology. Heart and Circulatory Physiology 2006, 290:H2247-H2256.
81. Saito T., Dai T., Asano R. The hyaluronan synthesis inhibitor 4-methylumbelliferone exhibits antitumor effects against mesenchymal-like canine mammary tumor cells. Oncology Letters 2013, 5:1068-1074.
82. Savani R.C., Cao G., Pooler P.M., Zaman A., Zhou Z., DeLisser H.M. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. The Journal of Biological Chemistry 2001, 276:36770-36778.
83. Scott J.E., Heatley F. Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. Biomacromolecules 2002, 3:547-553.
84. Semerano L., Clavel G., Assier E., Denys A., Boissier M.C. Blood vessels, a potential therapeutic target in rheumatoid arthritis?. Joint, Bone, Spine: Revue du Rhumatisme 2011, 78:118-123.
85. Shay E., He H., Sakurai S., Tseng S.C. Inhibition of angiogenesis by HC.HA, a complex of hyaluronan and the heavy chain of inter-alpha-inhibitor, purified from human amniotic membrane. Investigative Ophthalmology & Visual Science 2011, 52:2669-2678.
86. Shimizu T., Hoshino Y., Miyazaki H., Sato E. Angiogenesis and microvasculature in the female reproductive organs: Physiological and pathological implications. Current Pharmaceutical Design 2012, 18:303-309.
87. Singleton P.A., Bourguignon L.Y. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration. Cell Motility and the Cytoskeleton 2002, 53:293-316.
88. Singleton P.A., Bourguignon L.Y. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. Experimental Cell Research 2004, 295:102-118.
89. Singleton P.A., Chatchavalvanich S., Fu P., Xing J., Birukova A.A., Fortune J.A., et al. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circulation Research 2009, 104:978-986.
90. Singleton P.A., Dudek S.M., Chiang E.T., Garcia J.G. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB Journal 2005, 19:1646-1656.
91. Singleton P.A., Dudek S.M., Ma S.F., Garcia J.G. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. The Journal of Biological Chemistry 2006, 281:34381-34393.
92. Singleton P.A., Lennon F.E. Acute lung injury regulation by hyaluronan. Journal of Allergy & Therapy 2011, S4-003.
93. Singleton P.A., Mirzapoiazova T., Guo Y., Sammani S., Mambetsariev N., Lennon F.E., et al. High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness. American Journal of Physiology. Lung Cellular and Molecular Physiology 2010, 299:L639-L651.
94. Singleton P.A., Salgia R., Moreno-Vinasco L., Moitra J., Sammani S., Mirzapoiazova T., et al. CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. The Journal of Biological Chemistry 2007, 282:30643-30657.
95. Sironen R.K., Tammi M., Tammi R., Auvinen P.K., Anttila M., Kosma V.M. Hyaluronan in human malignancies. Experimental Cell Research 2011, 317:383-391.
96. Slevin M., Krupinski J., Gaffney J., Matou S., West D., Delisser H., et al. Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biology: Journal of the International Society for Matrix Biology 2007, 26:58-68.
97. St Hill C.A. Interactions between endothelial selectins and cancer cells regulate metastasis. Frontiers in Bioscience (Landmark Edition) 2011, 16:3233-3251.
98. Stern R. Devising a pathway for hyaluronan catabolism: Are we there yet?. Glycobiology 2003, 13:105R-115R.
99. Stern R. Hyaluronidases in cancer biology. Seminars in Cancer Biology 2008, 18:275-280.
100. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: An information-rich system. European Journal of Cell Biology 2006, 85:699-715.
101. Stern R., Kogan G., Jedrzejas M.J., Soltes L. The many ways to cleave hyaluronan. Biotechnology Advances 2007, 25:537-557.
102. Tammi M.I., Day A.J., Turley E.A. Hyaluronan and homeostasis: A balancing act. The Journal of Biological Chemistry 2002, 277:4581-4584.
103. Tammi R.H., Kultti A., Kosma V.M., Pirinen R., Auvinen P., Tammi M.I. Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Seminars in Cancer Biology 2008, 18:288-295.
104. Tan J.X., Wang X.Y., Li H.Y., Su X.L., Wang L., Ran L., et al. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. International Journal of Cancer. Journal International du Cancer 2011, 128:1303-1315.
105. Tan J.X., Wang X.Y., Su X.L., Li H.Y., Shi Y., Wang L., et al. Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis. PLoS One 2011, 6:e22836.
106. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. The Journal of Biological Chemistry 2004, 279:17079-17084.
107. Taylor K.R., Yamasaki K., Radek K.A., Di Nardo A., Goodarzi H., Golenbock D., et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. The Journal of Biological Chemistry 2007, 282:18265-18275.
108. Toole B.P. Hyaluronan: From extracellular glue to pericellular cue. Nature Reviews. Cancer 2004, 4:528-539.
109. Udabage L., Brownlee G.R., Nilsson S.K., Brown T.J. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Experimental Cell Research 2005, 310:205-217.
110. Vandenbroucke E., Mehta D., Minshall R., Malik A.B. Regulation of endothelial junctional permeability. Annals of the New York Academy of Sciences 2008, 1123:134-145.
111. Veeravalli K.K., Chetty C., Ponnala S., Gondi C.S., Lakka S.S., Fassett D., et al. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice. PLoS One 2010, 5:e11583.
112. Wang Y.Z., Cao M.L., Liu Y.W., He Y.Q., Yang C.X., Gao F. CD44 mediates oligosaccharides of hyaluronan-induced proliferation, tube formation and signal transduction in endothelial cells. Experimental Biology and Medicine (Maywood, N.J.) 2011, 236:84-90.
113. Wang A., de la Motte C., Lauer M., Hascall V. Hyaluronan matrices in pathobiological processes. The FEBS Journal 2011, 278(9):1412-1418. Epub 2011 Mar 25. 10.1111/j.1742-4658.2011.08069.x.
114. Wang D., Huang J., Wang X., Yu Y., Zhang H., Chen Y., et al. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. Biomaterials 2013, 34:7662-7673.
115. Wang H.S., Hung Y., Su C.H., Peng S.T., Guo Y.J., Lai M.C., et al. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1). Experimental Cell Research 2005, 304:116-126.
116. Weigel P.H., DeAngelis P.L. Hyaluronan synthases: A decade-plus of novel glycosyltransferases. The Journal of Biological Chemistry 2007, 282:36777-36781.
117. Wheeler-Jones C.P., Farrar C.E., Pitsillides A.A. Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention. Current Opinion in Investigational Drugs 2010, 11:997-1006.
118. Yang C., Liu Y., He Y., Du Y., Wang W., Shi X., et al. The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy. Biomaterials 2013, 34:6829-6838.
119. Yasuda T. Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macrophages through down-regulation of NF-kappaB via ICAM-1. Inflammation Research 2007, 56:246-253.